Others

Alembic Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on February 20, 2019 Published on February 20, 2019

With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Acetazolamide Extended-Release Capsules, 500 mg.

Please find enclosed herewith our press release.

We request you to kindly take the same on record.

Pdf Link: Alembic Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on February 20, 2019
This article is closed for comments.
Please Email the Editor